Istodax IV infusion 10mg, manufactured by Bristol-Myers Squibb, contains Romi depsin, a histone deacetylase (HDAC) inhibitor. It is used as an anticancer agent in cutaneous T-cell lymphoma (CTCL) and other peripheral T-cell lymphomas (PTCLs). This 10mg 1 bottle (with solution) has a YJ code of 4291440D1026.
Istodax IV infusion 10mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →